Publication | Closed Access
P1.15-004 An Open-Label, Multitumor Phase II Basket Study of Olaparib and Durvalumab (MEDIOLA): Results in Patients with Relapsed SCLC
32
Citations
0
References
2017
Year
OncologyMetronomic TherapyPathologyPharmacotherapyCancer TreatmentMedicineCancer ResearchRelapsed Sclc
No additional data available for this publication yet. Check back later!